The weekly litigation news digest is live. Subscribe now

IP Verse

Janssen Sciences Ireland Uc competitive analysis

Loading summary...

Latest oppositions filed by Janssen Sciences Ireland Uc

Explore patent oppositions filed by Janssen Sciences Ireland Uc against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Dec 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2397155
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayDANA FARBER CANCER INSTITUTESep 13, 2018

Latest patents of Janssen Sciences Ireland Uc opposed by its competitors

Explore Janssen Sciences Ireland Uc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2040671
Jan 24, 2018Aqueous Suspensions Of Tmc2781
EP2767539
Jul 12, 2017Pseudopolymorphic Forms Of A Hiv Protease Inhibitor1

Latest PTAB cases involving Janssen Sciences Ireland Uc

Discover the latest PTAB cases involving Janssen Sciences Ireland Uc, highlighting their recent legal challenges and patent disputes.

Last updated on: Dec 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Janssen Sciences Ireland Uc

IPR2015-01030Apr 9, 2015LUPINJANSSEN SCIENCES IRELAND UCInstitution Denied

Peer Comparison New

IP litigation analysis comparing Janssen Sciences Ireland Uc with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JANSSEN SCIENCES IRELAND UC12 - 1
COOKE27 - - -
DANA FARBER CANCER INSTITUTE - 1431
EMORY UNIVERSITY - 5 - -